Literature DB >> 19749182

Multimodality neuroimaging in Tourette syndrome: alpha-[11C] methyl-L-tryptophan positron emission tomography and diffusion tensor imaging studies.

Anita S D Saporta1, Harry T Chugani, Csaba Juhász, Malek I Makki, Otto Muzik, Benjamin J Wilson, Michael E Behen.   

Abstract

Previous studies in Tourette syndrome have reported lateralized abnormalities of neurotransmitters and microstructure of the cortico-striato-thalamo-cortical circuit. The authors analyzed the relationship between serotonin synthesis and microstructural changes in the subcortical structures (caudate nucleus, lentiform nucleus, and thalamus) related to this circuit, using alpha-[(11)C]methyl-L-tryptophan positron emission tomography (PET) and diffusion tensor imaging, respectively, in 16 children with Tourette syndrome. Correlations between diffusion tensor imaging and alpha-[(11)C]methyl-L-tryptophan PET asymmetry values were found in the caudate nucleus. The findings suggested higher serotonin synthesis on the side of more abnormal diffusion, characterized by lower fractional anisotropy and parallel diffusivity but higher perpendicular diffusivity. Altogether, these imaging abnormalities suggest asymmetric immature microstructure in the caudate nucleus associated with abnormally increased serotonin synthesis in Tourette syndrome. The observed diffusion tensor imaging changes are likely related to abnormal connectivity in the cortico-striato-thalamo-cortical circuit, which may result in cortical disinhibition and increased serotonin synthesis; this could provide a new therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749182     DOI: 10.1177/0883073809339394

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

Review 1.  A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Authors:  Aysegul Gunduz; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

2.  Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.

Authors:  Alexandre Berney; Marco Leyton; Paul Gravel; Igor Sibon; Debbie Sookman; Pedro Rosa Neto; Mirko Diksic; Akio Nakai; Gilbert Pinard; Christo Todorov; Hidehiko Okazawa; Pierre Blier; Thomas Edward Nordahl; Chawki Benkelfat
Journal:  Arch Gen Psychiatry       Date:  2011-03-07

3.  Pediatric Tourette syndrome: insights from recent neuroimaging studies.

Authors:  Jessica A Church; Bradley L Schlaggar
Journal:  J Obsessive Compuls Relat Disord       Date:  2014-10-01       Impact factor: 1.677

Review 4.  Molecular imaging of movement disorders.

Authors:  Karlo J Lizarraga; Alessandra Gorgulho; Wei Chen; Antonio A De Salles
Journal:  World J Radiol       Date:  2016-03-28

5.  Altered frontal-mediated inhibition and white matter connectivity in pediatric chronic tic disorders.

Authors:  Adrienne B Bruce; Weihong Yuan; Donald L Gilbert; Paul S Horn; Hannah S Jackson; David A Huddleston; Steve W Wu
Journal:  Exp Brain Res       Date:  2021-01-18       Impact factor: 1.972

6.  Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms.

Authors:  Kirsten R Müller-Vahl; Julian Grosskreutz; Tino Prell; Jörn Kaufmann; Nils Bodammer; Thomas Peschel
Journal:  BMC Neurosci       Date:  2014-01-07       Impact factor: 3.288

Review 7.  PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications.

Authors:  Pierpaolo Alongi; Leonardo Iaccarino; Daniela Perani
Journal:  Front Neurol       Date:  2014-09-23       Impact factor: 4.003

8.  Alterations in the microstructure of white matter in children and adolescents with Tourette syndrome measured using tract-based spatial statistics and probabilistic tractography.

Authors:  Hilmar P Sigurdsson; Sophia E Pépés; Georgina M Jackson; Amelia Draper; Paul S Morgan; Stephen R Jackson
Journal:  Cortex       Date:  2018-04-12       Impact factor: 4.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.